Imunon, Inc. Interest Payable, Current
Imunon, Inc. (IMNN) had Interest Payable, Current of $37.58 thousand as of 2022-12-31, per its 10-K filed 2024-03-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2024-03-28
- 2022-12-31: Interest Payable, Current $37.58K.
- 2021-09-30: Interest Payable, Current $16.25K.
- 2021-06-30: Interest Payable, Current $7.04K.
| Period end | Interest Payable, Current |
|---|---|
| 2022-12-31 | $37.58K 10-K · filed 2024-03-28 |
| 2021-09-30 | $16.25K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $7.04K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |